[Skip to Content]
[Skip to Content Landing]

Associations of Depression, Anxiety, Worry, Perceived Stress, and Loneliness Prior to Infection With Risk of Post–COVID-19 Conditions

Educational Objective
To identify the key insights or developments described in this article
1 Credit CME
Key Points

Question  Is psychological distress before SARS-CoV-2 infection associated with risk of COVID-19–related symptoms lasting 4 weeks or longer, known as post–COVID-19 conditions?

Findings  This cohort study found that among participants who did not report SARS-CoV-2 infection at baseline (April 2020) and reported a positive SARS-CoV-2 test result over 1 year of follow-up (N = 3193), depression, anxiety, perceived stress, loneliness, and worry about COVID-19 were prospectively associated with a 1.3- to 1.5-fold increased risk of self-reported post–COVID-19 conditions, as well as increased risk of daily life impairment related to post–COVID-19 conditions.

Meaning  In this study, preinfection psychological distress was associated with risk of post–COVID-19 conditions and daily life impairment in those with post–COVID-19 conditions.

Abstract

Importance  Few risk factors for long-lasting (≥4 weeks) COVID-19 symptoms have been identified.

Objective  To determine whether high levels of psychological distress before SARS-CoV-2 infection, characterized by depression, anxiety, worry, perceived stress, and loneliness, are prospectively associated with increased risk of developing post–COVID-19 conditions (sometimes called long COVID).

Design, Setting, and Participants  This prospective cohort study used data from 3 large ongoing, predominantly female cohorts: Nurses’ Health Study II, Nurses’ Health Study 3, and the Growing Up Today Study. Between April 2020 and November 2021, participants were followed up with periodic surveys. Participants were included if they reported no current or prior SARS-CoV-2 infection at the April 2020 baseline survey when distress was assessed and returned 1 or more follow-up questionnaires.

Exposures  Depression, anxiety, worry about COVID-19, perceived stress, and loneliness were measured at study baseline early in the pandemic, before SARS-CoV-2 infection, using validated questionnaires.

Main Outcomes and Measures  SARS-CoV-2 infection was self-reported during each of 6 monthly and then quarterly follow-up questionnaires. COVID-19–related symptoms lasting 4 weeks or longer and daily life impairment due to these symptoms were self-reported on the final questionnaire, 1 year after baseline.

Results  Of 54 960 participants, 38.0% (n = 20 902) were active health care workers, and 96.6% (n = 53 107) were female; the mean (SD) age was 57.5 (13.8) years. Six percent (3193 participants) reported a positive SARS-CoV-2 test result during follow-up (1-47 weeks after baseline). Among these, probable depression (risk ratio [RR], 1.32; 95% CI = 1.12-1.55), probable anxiety (RR = 1.42; 95% CI, 1.23-1.65), worry about COVID-19 (RR, 1.37; 95% CI, 1.17-1.61), perceived stress (highest vs lowest quartile: RR, 1.46; 95% CI, 1.18-1.81), and loneliness (RR, 1.32; 95% CI, 1.08-1.61) were each associated with post–COVID-19 conditions (1403 cases) in generalized estimating equation models adjusted for sociodemographic factors, health behaviors, and comorbidities. Participants with 2 or more types of distress prior to infection were at nearly 50% increased risk for post–COVID-19 conditions (RR, 1.49; 95% CI, 1.23-1.80). All types of distress were associated with increased risk of daily life impairment (783 cases) among individuals with post–COVID-19 conditions (RR range, 1.15-1.51).

Conclusions and Relevance  The findings of this study suggest that preinfection psychological distress may be a risk factor for post–COVID-19 conditions in individuals with SARS-CoV-2 infection. Future work should examine the biobehavioral mechanism linking psychological distress with persistent postinfection symptoms.

Sign in to take quiz and track your certificates

Buy This Activity

JN Learning™ is the home for CME and MOC from the JAMA Network. Search by specialty or US state and earn AMA PRA Category 1 Credit(s)™ from articles, audio, Clinical Challenges and more. Learn more about CME/MOC

CME Disclosure Statement: Unless noted, all individuals in control of content reported no relevant financial relationships. If applicable, all relevant financial relationships have been mitigated.

Article Information

Accepted for Publication: July 14, 2022.

Published Online: September 7, 2022. doi:10.1001/jamapsychiatry.2022.2640

Corresponding Author: Siwen Wang, MD, Department of Nutrition, Harvard T.H. Chan School of Medicine, 655 Huntington Ave, Bldg II, Room 316, Boston, MA 02215 (siwenwang@hsph.harvard.edu).

Correction: This article was corrected on September 28, 2022, to change the article to open access status.

Open Access: This is an open access article distributed under the terms of the CC-BY License. © 2022 Wang S et al. JAMA Psychiatry.

Author Contributions: Dr Wang had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.

Concept and design: Wang, Quan, Chavarro, Kubzansky, Koenen, Branch-Elliman, Roberts.

Acquisition, analysis, or interpretation of data: Wang, Chavarro, Slopen, Kubzansky, Koenen, Kang, Weisskopf, Branch-Elliman, Roberts.

Drafting of the manuscript: Wang, Quan, Chavarro, Roberts.

Critical revision of the manuscript for important intellectual content: All authors.

Statistical analysis: Wang, Koenen, Kang.

Obtained funding: Chavarro, Slopen, Kubzansky, Koenen.

Administrative, technical, or material support: Wang, Chavarro, Kubzansky, Weisskopf.

Supervision: Kubzansky, Weisskopf, Roberts.

Conflict of Interest Disclosures: Dr Chavarro reported grants to his institution from the National Institutes of Health (NIH) during the conduct of the study and grants to his institution from the NIH, US Food and Drug Administration, and Centers for Disease Control and Prevention outside the submitted work. Dr Kubzansky reported grants from the NIH and support for data collection from the Lee Kum Sheung Center for Health and Happiness during the conduct of the study. Dr Koenen reported a Dean’s Acceleration Award internal grant from Harvard T.H. Chan School of Public Health during the conduct of the study. Dr Branch-Elliman reported being the site principal investigator for a COVID-19 therapeutics study funded by Gilead Sciences (funds provided to her institution) during the conduct of the study. No other disclosures were reported.

Funding/Support: This research was supported by a grant to Dr Roberts from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (3R01HD094725-02S1). Other support includes grants U01HL145386, R24ES028521, U01 CA176726, R01 CA67262, and R01 HD057368 from the National Institutes of Health; the Dean’s Fund for Scientific Advancement Acceleration Award from the Harvard T.H. Chan School of Public Health; and the Massachusetts Consortium on Pathogen Readiness Evergrande COVID-19 Response Fund Award. Dr Branch-Elliman is supported by Veterans Affairs Health Services Research and Development Service funds (IIR 20-076, INV 20-099, IIR 20-101).

Role of the Funder/Sponsor: The funders had no role in design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.

Disclaimer: Views expressed are those of the authors and do not necessarily represent those of the US government.

AMA CME Accreditation Information

Credit Designation Statement: The American Medical Association designates this Journal-based CME activity activity for a maximum of 1.00  AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to:

  • 1.00 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program;;
  • 1.00 Self-Assessment points in the American Board of Otolaryngology – Head and Neck Surgery’s (ABOHNS) Continuing Certification program;
  • 1.00 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program;
  • 1.00 Lifelong Learning points in the American Board of Pathology’s (ABPath) Continuing Certification program; and
  • 1.00 credit toward the CME [and Self-Assessment requirements] of the American Board of Surgery’s Continuous Certification program

It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting MOC credit.

Close
Want full access to the AMA Ed Hub?
After you sign up for AMA Membership, make sure you sign in or create a Physician account with the AMA in order to access all learning activities on the AMA Ed Hub
Buy this activity
Close
Want full access to the AMA Ed Hub?
After you sign up for AMA Membership, make sure you sign in or create a Physician account with the AMA in order to access all learning activities on the AMA Ed Hub
Buy this activity
Close
With a personal account, you can:
  • Access free activities and track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
Education Center Collection Sign In Modal Right
Close

Name Your Search

Save Search
With a personal account, you can:
  • Access free activities and track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
Close
Close

Lookup An Activity

or

My Saved Searches

You currently have no searches saved.

Close

My Saved Courses

You currently have no courses saved.

Close